The 29th Annual Procrastinators Marathon: Hot Topic Updates in Pharmacy

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

This knowledge-based CPE activity will provide the healthcare professional with current and emerging evidence-based updates to help ensure best practices, minimize preventable healthcare related cost, and provide optimal patient care.

Event Topics and Faculty:

What Changed in Oncology While You Were Busy
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, FASTCT

Cardiovascular Kidney Metabolic (CKM) Syndrome Decoded: Translating Guidelines into Pharmacy Practice
Lauren Anderson, PharmD, BCACP

Cannabis 360: Products, Pharmacology, and Policy
Kristen Nagy, PharmD, BCPS, BCPP, CPP

Pharmacist-Initiated Hormonal Contraception in NC
Mollie Ashe Scott, Pharm.D., BCACP, CPP, FASHP, FNCAP

The Menopause Moment: A Review for Pharmacists
Amanda Savage, PharmD

Considerations for Optimal Asthma Management
Dennis Williams, Pharm.D., BCPS, AE-C

Continuing Education Credit For Pharmacists:
The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE#0046-9999-26-225-L99-P(Pharmacist) provides 6.0 contact hours of continuing pharmacy education credit. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks. **No partial credit will be available**

Contact emily.barnes@advocatehealth.org with questions.

Upcoming Pharmacy Live Webinars

New Drug Update 2026: A Formulary Approach
November 3rd, 2026 | 6:30pm-8:30pm
The 29th Annual Procrastinators Marathon: Hot Topic Updates in Pharmacy
November 20th, 2026 | 8:00am-3:00pm
The Evolving Landscape of Incretin Therapies: Evidence, Outcomes, and Emerging Applications
December 2nd, 2026 | 6:30pm-8:30pm

Live Webinar Information
This Live Webinar will be broadcast with Zoom. Instructions to join the Live Webinar will be emailed prior to the event. You can test your computer by going to the Zoom Test Page
Registering for and attending a South Piedmont AHEC program authorizes South Piedmont AHEC to take audio, video, and/or still images to be used for promotional and educational purposes. If you have concerns, please speak with a South Piedmont AHEC team member.

Objectives

• KENNEDY: Understand the role of the pharmacist in managing toxicities with bispecific therapies
• KENNEDY: Describe toxicities with immunotherapies and how to manage them
• KENNEDY: Discuss the difference between hazardous medications and handling
• KENNEDY: Review new oncology therapeutic categories (e.g. gene therapy)
• ANDERSON: Define Cardiovascular Kidney Metabolic (CKM) Syndrome
• ANDERSON: Describe the link between social determinants of health (SDoH) and CKM Syndrome
• ANDERSON: Identify evidence-based pharmacotherapy that reduces cardiovascular, kidney, and metabolic risk in CKM Syndrome
• ANDERSON: Construct an evidence-based care plan to treat patients with CKM and Chronic Kidney Disease (CKD)
• NAGY: Describe the pharmacology of cannabis, including major cannabinoids and their mechanisms of action
• NAGY: Differentiate between various cannabis product formulations and their clinical implications
• NAGY: Assess federal and state regulatory requirements and integrate compliance considerations into patient care decisions
• SCOTT: Provide an update about hormonal contraceptives and the CDC Medical Eligibility Criteria for Contraceptive Use
• SCOTT: Discuss the uptake of pharmacist-prescribed hormonal contraception across North Carolina
• SCOTT: Discuss workflows for providing contraception care
• SCOTT: Describe lessons learned about barriers and facilitators for implementation of contraception services in community pharmacies
• SAVAGE: Describe the pathophysiology and clinical characteristics of perimenopause and menopause
• SAVAGE: Identify the signs and symptoms associated with perimenopause and menopause
• SAVAGE: Recognize the risks and benefits of hormone therapy (HT) and non-hormonal treatments in managing perimenopausal and menopausal symptoms
• SAVAGE: Name the topical and systemic forms of HT
• SAVAGE: Explain nonpharmacologic therapy for menopausal symptoms
• SAVAGE: Determine the desired therapeutic outcomes for a patient taking HT
• SAVAGE: Explain to patients the treatment options, benefits, risks, and monitoring of HT
• WILLIAMS: Describe an evidence-based approach to chronic asthma management
• WILLIAMS: Discuss considerations for rescue therapy for acute asthma symptoms
• WILLIAMS: Review the role of biologic medications in asthma management

Sessions